Personalizing Enzyme Therapy to Improve Pancreatitis in Kids
Ochsner Health
When on pancreatic enzyme replacement therapy, the mean acute pancreatitis annual incidence rate decreased from 3.14 to 0.71
Enzymes
FDA Approves Recombinant Enzyme to Treat Rare Blood Clotting Disorder
U.S. Food and Drug Administration
Adzynma safely and effectively “filled in” for the mutated ADAMTS13 enzyme in patients with cTTP
New Protein Target to Suppress Triple-Negative Breast Cancer Growth
Baylor College of Medicine
Blocking proteins that activate the AGC group of enzymes has been shown to have tumor-suppressing effects
Click Chemistry Helps Create Sialidase-Based Anticancer Therapy
University College London
Study opens up new possibilities for how cutting-edge cancer immunotherapies might be built in future
Recombinant Protein Administered to First Infant with ENPP1 Deficiency
Inozyme Pharma Inc.
Phase 1b trial of INZ-701 aimed to improve quality of life in patients with rare, genetic diseases
New Family of Enzymes Reveals Fungal Pathogens' Weakness
Canadian Glycomics Network
GlycoNet scientists share findings that could lead to therapeutics to treat fungal infections
Novel Experimental Treatment for Chronic Lung Diseases
Queen’s University Belfast
Symptoms associated with both diseases can be alleviated by inhibiting the activity of an enzyme found in the lungs
A Trojan Horse Delivery for Treating a Rare, Potentially Deadly, Blood-Clotting Disorder
Today's Clinical Lab
In this possible treatment, platelet blood cells carry an enzyme needed to prevent clots in TTP, while hiding the enzyme from autoantibody neutralization
